Author: fidelityit

Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile
Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum both taking place on Thursday March 25th
Avicanna Enters Strategic Partnership with Al Harrington’s, Viola, for commercialization of Viola branded products in Canada
Avicanna Closes Non-Brokered Private Placement Raising $5.6 Million.
Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States
Avicanna Launches RHO Phyto™ Topical Gels in Canada and Initiates Clinical Studies
Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with University of Guelph and Provides Research and Management Team Updates
Avicanna Advances Pharmaceutical Epilepsy Program with Collaboration with The University Health Network and GMP Manufacturing Of Its First Pharmaceutical Preparation
Avicanna Announces Exercise And Closing Of Over-Allotment Option
Avicanna To Expand Access To Its Advanced And Evidence-based Rho Phyto Medical Products Through Provincial Retailers Across Canada